Skip to content

Validation of a Semi-automatized Method to Detect Cyclic Hyperinflation on CT-scan in ARDS

Validation of a Semi-automatized Method to Detect Cyclic Hyperinflation on CT-scan in ARDS

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03870009
Acronym
CT4-ARDS
Enrollment
31
Registered
2019-03-11
Start date
2019-05-21
Completion date
2021-02-16
Last updated
2025-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome (ARDS)

Keywords

ARDS, computed tomography, cyclic hyperinflation, mechanical ventilation

Brief summary

This study aims to validate a semi-automatized method to quantify cyclic hyperinflation on CT-scan of ARDS patients. The gold standard will be cyclic hyperinflation assessed on the same CT scan, using manual segmentation of the lung.

Interventions

The patient will be installed on the scanner bed. Two series of tomographic sections will be acquired: one during an expiratory break, the other during an inspiratory pause. cyclic hyperinflation measured by semi-automatic segmentation and by manual segmentation

Sponsors

Hospices Civils de Lyon
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ARDS patients defined by the Berlin definition * invasive mechanical ventilation with an arterial oxygen pressure (PaO2)/inspired fraction of oxygen (FiO2) ratio ≤ 200 mm Hg * Indication of CT scan identified by the clinician in charge * oesophageal catheter already inserted

Exclusion criteria

* requirement of contrast agent for a chest CT-scan * ARDS criteria present for more than 72 hours * Chronic Obstructive Pulmonary Disease (COPD) on a previous lung function test * pneumothorax or bronchopleural fistula * patient without both sedation and neuromuscular blocking agents * contra-indication to transport to the imaging facility * treatment with extracorporeal membrane oxygenation or extracorporeal carbon dioxide (CO2) removal * Latex or curare allergy * patient previously included in the study * pregnancy * patient under limitation of care * patient under an exclusion period following inclusion in another clinical trial * patient under a legal protective measure * patient unaffiliated with social security * inform consent not obtained by next of kin

Design outcomes

Primary

MeasureTime frameDescription
cyclic hyperinflation measured by semi-automated segmentation2 hours after inclusionBias and precision of semi-automated measure will be assessed with the Bland and Altman Technique, using cyclic hyperinflation by manual segmentation as a reference
cyclic hyperinflation measured by manual segmentation2 hours after inclusionBias and precision of semi-automated measure will be assessed with the Bland and Altman Technique, using cyclic hyperinflation by manual segmentation as a reference

Secondary

MeasureTime frameDescription
prevalence of cyclic hyperinflation on CT scan2 hours after inclusioncyclic hyperinflation assessed by manual segmentation on CT scan
area under receiver operating characteristic (ROC) curve of respiratory system driving pressure to detect cyclic hyperinflation assessed by manual segmentation2 hours after inclusion
area under ROC curve of transpulmonary driving pressure to detect cyclic hyperinflation assessed by manual segmentation2 hours after inclusion

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026